Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
Systematic review |
140 women 2 RCTs in this analysis |
Proportion of women who had a premature birth
5/70 (7%) with low-dose aspirin alone (75–81 mg/day) 11/70 (16%) with low-dose aspirin plus unfractionated heparin (5000 U twice daily) |
RR 0.5 95% CI 0.2 to 1.3 This analysis was likely to have been underpowered to detect clinically important differences between groups |
Not significant | |
Systematic review |
140 women 2 RCTs in this analysis |
Proportion of women who had fetal growth restriction
2/70 (3%) with low-dose aspirin alone (75–81 mg/day) 6/70 (9%) with low-dose aspirin plus unfractionated heparin (5000 U twice daily) |
RR 0.3 95% CI 0.1 to 1.6 This analysis was likely to have been underpowered to detect clinically important differences between groups |
Not significant | |
RCT |
72 women |
Adverse effects
with low-dose aspirin alone (80 mg/day) with low-dose aspirin plus unfractionated heparin (5000 U twice daily) Absolute numbers not reported |
Significance not assessed The trial reported that it was randomised, but the method of randomisation was not described. The level of blinding was not reported |